The CNIC and Canadians for CANDU Sign a Memorandum of Understanding to Collaborate in Support of Canadian-made Isotopes

Hamilton, ON – February 5th, 2026 – The Canadian Nuclear Isotope Council (CNIC) and Canadians for CANDU (C4C) are pleased to announce the signing of a Memorandum of Understanding (MOU) between the two organizations. The MOU details how the two parties will align advocacy initiatives and expand information sharing.

The agreement was signed at McMaster University on February 4th as part of a World Cancer Day reception attended by over one hundred industry, political, and academic leaders celebrating the collective impact of Canada’s nuclear sector.

The C4C campaign highlights the critical role that Canada-owned CANDU technology plays in providing clean energy for Canadians, powering millions of homes and businesses. As CANDU technology becomes an increasingly critical component of the global isotope supply chain, C4C has also expanded its advocacy and awareness-building efforts to showcase this important aspect of the CANDU story.

Canada’s fleet of CANDU reactors located at Bruce Power and Ontario Power Generation (OPG) nuclear generating stations across Ontario have produced life-changing Cobalt-60 isotopes for decades, supporting the sterilization of over 40% of the world’s single-use medical equipment and enabling therapy for hundreds of thousands of brain and breast cancer patients globally. In 2022, Bruce Power became the world’s first commercial power reactor source of Lutetium-177, an innovative therapeutic isotope used to treat prostate cancer, and more recently, OPG’s Darlington reactor has been outfitted for significant Molybdenum-99 production, which will support additional Canadian capacity for diagnostic imaging.

As the CNIC expands its awareness-building efforts from coast-to-coast, at both the federal and provincial levels, the unique role that Canada’s current CANDU reactors play in irradiating isotopes at an unmatched scale while producing clean energy remains a critical part its advocacy. This uniquely Canadian success story continues to resonate with elected officials and staff across the country.

“I was pleased to sign this new agreement on behalf of the CNIC, marking the start of our new collaborative relationship with the Canadians for CANDU campaign. We’re excited to work in partnership with C4C to raise awareness for the important role that Canada’s current fleet of CANDU reactors plays in supporting global health,” said Melody Greaves, Executive Director of the CNIC. “The C4C campaign has resonated with leaders across the country, and we’re excited to work together to advance our mutual interests at such a pivotal time for Canada’s nuclear and isotope industries.”

“This MOU formalizes a strong and natural partnership between Canadians for CANDU and the Canadian Nuclear Isotope Council,” said Maura McDonald, Vice-President, Key Account and Stakeholder Management, Candu Energy International. “Canada’s CANDU reactors are already delivering enormous value by producing clean, reliable electricity while supplying life‑saving medical isotopes to patients around the world. Working more closely with the CNIC will help ensure this uniquely Canadian success story is better understood by decision‑makers and the public alike, at a time when global demand for isotopes and clean energy has never been greater.”

Learn more about the Canadians for CANDU campaign at https://canadiansforcandu.com/

About the Canadian Nuclear Isotope Council

The Canadian Nuclear Isotope Council (CNIC) is an independent, not-for-profit advocacy and member services organization. The CNIC supports over 115 members from across science, academia, healthcare, and nuclear-sector organizations dedicated to maintaining Canada’s position as a global leader in the production of life-saving isotopes. The CNIC raises awareness and advocates for long-term policies that support health care innovation and will save countless lives for decades to come.

To learn more about the CNIC, visit www.CanadianIsotopes.ca and follow us on Facebook, Twitter, and LinkedIn.

For more information, please contact:

Evan Cameron
Manager, Public Affairs & Communications
Canadian Nuclear Isotope Council
evan.cameron@canadianisotopes.ca